Impax Laboratories, Inc. (Nasdaq: IPXL) announced that it is commencing shipment of authorized generic RENVELA (sevelamer carbonate 800 mg tablets) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE